230 related articles for article (PubMed ID: 24074231)
21. A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
Fukuda-Tsuru S; Anabuki J; Abe Y; Yoshida K; Ishii S
Eur J Pharmacol; 2012 Dec; 696(1-3):194-202. PubMed ID: 23022337
[TBL] [Abstract][Full Text] [Related]
22. Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients.
Bopp A; De Bona KS; Bellé LP; Moresco RN; Moretto MB
Fundam Clin Pharmacol; 2009 Aug; 23(4):501-7. PubMed ID: 19709327
[TBL] [Abstract][Full Text] [Related]
23. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes.
Kamble B; Talreja S; Gupta A; Patil D; Pathak D; Moothedath I; Duraiswamy B
Nanomedicine (Lond); 2013 Aug; 8(8):1295-305. PubMed ID: 23259778
[TBL] [Abstract][Full Text] [Related]
24. Antihyperglycaemic and antioxidant effect of hyponidd, an ayurvedic herbomineral formulation in streptozotocin-induced diabetic rats.
Babu PS; Stanely Mainzen Prince P
J Pharm Pharmacol; 2004 Nov; 56(11):1435-42. PubMed ID: 15525451
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
26. Selective COX-2 inhibition by a Pterocarpus marsupium extract characterized by pterostilbene, and its activity in healthy human volunteers.
Hougee S; Faber J; Sanders A; de Jong RB; van den Berg WB; Garssen J; Hoijer MA; Smit HF
Planta Med; 2005 May; 71(5):387-92. PubMed ID: 15931573
[TBL] [Abstract][Full Text] [Related]
27. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M
Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564
[TBL] [Abstract][Full Text] [Related]
28. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
[TBL] [Abstract][Full Text] [Related]
29. Hypoglycemic activity of Gymnema sylvestre extracts on oxidative stress and antioxidant status in diabetic rats.
Kang MH; Lee MS; Choi MK; Min KS; Shibamoto T
J Agric Food Chem; 2012 Mar; 60(10):2517-24. PubMed ID: 22360666
[TBL] [Abstract][Full Text] [Related]
30. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
Deacon CF; Mannucci E; Ahrén B
Diabetes Obes Metab; 2012 Aug; 14(8):762-7. PubMed ID: 22471248
[TBL] [Abstract][Full Text] [Related]
31. [Structural alterations in pancreatic islets in streptozotocin-induced diabetic rats treated with of bioactive additive on the basis of Gymnema sylvestre].
Snigur GL; Samokhina MP; Pisarev VB; Spasov AA; Bulanov AE
Morfologiia; 2008; 133(1):60-4. PubMed ID: 19069418
[TBL] [Abstract][Full Text] [Related]
32. Role of zonulin and GLP-1/DPP-IV in alleviation of diabetes mellitus by peptide/polypeptide fraction of Aloe vera in streptozotocin- induced diabetic wistar rats.
Babu SN; Govindarajan S; Vijayalakshmi MA; Noor A
J Ethnopharmacol; 2021 May; 272():113949. PubMed ID: 33610707
[TBL] [Abstract][Full Text] [Related]
33. Antidiabetic activity of heart wood of Pterocarpus marsupium Roxb. and analysis of phytoconstituents.
Mishra A; Srivastava R; Srivastava SP; Gautam S; Tamrakar AK; Maurya R; Srivastava AK
Indian J Exp Biol; 2013 May; 51(5):363-74. PubMed ID: 23821824
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV.
Rohani ; Febrina E; Wahyuni IS; Levita J
Drug Des Devel Ther; 2023; 17():3473-3491. PubMed ID: 38024536
[TBL] [Abstract][Full Text] [Related]
35. Renoprotective Effects, Protein Thiols and Liver Glycogen Content of Alloxan-induced Diabetic Rats Treated with Different Fractions of Heartwood of Pterocarpus marsupium.
Bhata V; Nayak BS
Nat Prod Commun; 2015 Nov; 10(11):1843-6. PubMed ID: 26749811
[TBL] [Abstract][Full Text] [Related]
36. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
Cuthbertson J; Patterson S; O'Harte FP; Bell PM
Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
[TBL] [Abstract][Full Text] [Related]
37. 7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one is a novel competitive and selective inhibitor of dipeptidyl peptidase IV with an antihyperglycemic activity.
Yamazaki K; Yasuda N; Inoue T; Nagakura T; Kira K; Shinoda M; Saeki T; Tanaka I
J Pharmacol Exp Ther; 2006 Dec; 319(3):1253-7. PubMed ID: 16980568
[TBL] [Abstract][Full Text] [Related]
38. (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors.
Thomas L; Eckhardt M; Langkopf E; Tadayyon M; Himmelsbach F; Mark M
J Pharmacol Exp Ther; 2008 Apr; 325(1):175-82. PubMed ID: 18223196
[TBL] [Abstract][Full Text] [Related]
39. Plants Fagonia cretica L. and Hedera nepalensis K. Koch contain natural compounds with potent dipeptidyl peptidase-4 (DPP-4) inhibitory activity.
Saleem S; Jafri L; ul Haq I; Chang LC; Calderwood D; Green BD; Mirza B
J Ethnopharmacol; 2014 Oct; 156():26-32. PubMed ID: 25169215
[TBL] [Abstract][Full Text] [Related]
40. Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: a new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554.
Banno Y; Miyamoto Y; Sasaki M; Oi S; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Tsubotani S; Tani A; Funami M; Tawada M; Yamamoto Y; Aertgeerts K; Yano J; Maezaki H
Bioorg Med Chem; 2011 Aug; 19(16):4953-70. PubMed ID: 21764322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
